Events & Presentations
Upcoming Events
| Date | Event Details | Remind Me |
|---|---|---|
|
Nov 30, 2021
|
Piper Sandler 33rd Annual Healthcare Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
|
Dec 2, 2021 1:00 PM EST
|
4th Annual Evercore ISI HealthCONx Conference
Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation
|
|
|
Dec 3, 2021
|
18th Global Cardiovascular Clinical Trialists Forum
James Hamilton, MD, MBA, Arrowhead’s senior vice president of discovery & translational medicine, will participate in a panel discussion titled, “Developments in Hypertriglyceridemia Trials”
|
Archived Events
| Date | Event Details |
|---|---|
|
Mar 27 - Mar 30, 2019
|
CSHL Meeting: RNA & Oligonucleotide Therapeutics
View Presentation 11.5 MB
Cold Spring Harbor, NY
Dr. Hamilton will deliver an oral presentation titled, “Cardiovascular and lipid disorders - A next frontier for TRiMTM RNAi”
|
|
Mar 26, 2019 4:35 PM EDT
|
Oligonucleotide & Precision Therapeutics (OPT) Congress
View Presentation 11.5 MB
Cambridge, MA
James Hamilton, M.D., Arrowhead’s vice president of clinical development, will deliver an oral presentation titled, “siRNA Clinical Development Based on the TRiMTM Platform”
|
|
Mar 18, 2019 9:30 AM EDT
|
Jefferies HBV Investor Summit
New York
Dr. Given will participate in a fireside chat presentation with Maury Raycroft, Ph.D., Jefferies Biotech Analyst
|
|
Mar 12, 2019 4:20 PM EDT
|
Barclays Global Healthcare Conference 2019
Miami
Bruce Given, M.D., Arrowhead’s chief operating officer, will deliver a corporate presentation.
|
|
Feb 22, 2019
|
APASL 2019
View Presentation 770.9 KB
Dr. Edward Gane will deliver a poster presentation titled, “RNA interference (RNAi) in chronic hepatitis B (CHB): Data from Phase 2 study with JNJ-3989”
|
|
Feb 7, 2019 4:30 PM EST
|
Arrowhead Pharmaceuticals 2019 First Quarter Results
Prepared Remarks 165.2 KB
|
|
Dec 11, 2018 4:30 PM EST
|
Arrowhead 2018 Fiscal Year End Results
|
|
Nov 28, 2018
|
30th Annual Piper Jaffray Healthcare Conference
New York, NY
November 28, 3:30 p.m. EST – Dr. Anzalone will participate in a fireside chat
|
|
Nov 16, 2018
|
China Nucleic Acids
View Presentation 9.3 MB
Guangzhou, China
November 16, 11:20 – Dr. Li will deliver an oral presentation titled, “TRiMTM Platform Based RNAi Therapeutics for AATD and Cardiometabolic Diseases”
|
|
Nov 15, 2018
|
Jefferies 2018 London Healthcare
View Presentation 10.5 MB
London
November 15, 2:00 p.m. GMT – Christopher Anzalone, Ph.D., Arrowhead’s president and chief executive officer, will deliver a corporate presentation
|